NextCell listed on the Life Science Hotlist
NextCell Pharma AB ("NXTCL") announces that Invest Stockholm has now placed NXTCL on the Life Science Hotlist.The Stockholm-Uppsala Life Science Investment Hotlist is curated by Invest Stockholm and lists the most promising and innovative companies active in the field of life science. NXTCL with both its stem cell banking and drug development business is an ideal candidate for this list. The company develops novel treatments with stem cells from the umbilical cord. In umbilical cord and umbilical cord tissue there are young and viable stem cells that can be collected without any medical